Related references
Note: Only part of the references are listed.Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini et al.
BLOOD (2012)
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M. Arnold et al.
BLOOD (2012)
Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults
Mark Crowther et al.
BLOOD (2011)
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
Francesco Zaja et al.
BLOOD (2010)
Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells
Roberto Stasi
SEMINARS IN HEMATOLOGY (2010)
Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases
Guillaume Bussone et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Autoimmune hemolytic anemia
D. Dierickx et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Rituximab in the treatment of autoimmune haematological disorders
Bernadette Garvey
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Francesco Zaja et al.
HAEMATOLOGICA (2008)
Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias
Aarati Rao et al.
PEDIATRIC BLOOD & CANCER (2008)
Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients
Giovanni D'Arena et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2006)
Rituximab in chronic cold agglutinin disease:: a prospective study of 20 patients
C Schöllkopf et al.
LEUKEMIA & LYMPHOMA (2006)
Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab
S Ramanathan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
S Berentsen et al.
BLOOD (2004)
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
M Zecca et al.
BLOOD (2003)
Rituximab for immune cytopenia in adults: Idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome
TD Shanafelt et al.
MAYO CLINIC PROCEEDINGS (2003)
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia
N Gupta et al.
LEUKEMIA (2002)
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus
S Perrotta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab
J Chemnitz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Treatment of childhood autoimmune haemolytic anaemia with rituximab
P Quartier et al.
LANCET (2001)
Treatment of autoimmune hemolytic anemias
LD Petz
CURRENT OPINION IN HEMATOLOGY (2001)
Share Paper
